DocuSign (NASDAQ:DOCU – Get Free Report)‘s stock had its “hold” rating reaffirmed by research analysts at Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports.
Several other equities research analysts also recently issued reports on the company. JPMorgan Chase & Co. upped their price target on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Tuesday, December 3rd. Piper Sandler upped their price target on DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Robert W. Baird increased their target price on DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. HSBC restated a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $90.00 price objective (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $92.45.
Check Out Our Latest Research Report on DocuSign
DocuSign Trading Down 0.3 %
Insider Buying and Selling
In other news, CEO Allan C. Thygesen sold 7,763 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the transaction, the chief executive officer now owns 100,062 shares of the company’s stock, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the transaction, the director now owns 7,736 shares of the company’s stock, valued at approximately $731,825.60. This represents a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 685,773 shares of company stock valued at $66,032,726 over the last 90 days. Company insiders own 1.66% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of DOCU. KBC Group NV increased its stake in DocuSign by 209.8% in the 3rd quarter. KBC Group NV now owns 1,156,874 shares of the company’s stock worth $71,830,000 after buying an additional 783,419 shares during the period. Fiera Capital Corp purchased a new position in DocuSign during the 4th quarter valued at about $47,920,000. Principal Financial Group Inc. boosted its stake in shares of DocuSign by 3,026.7% during the fourth quarter. Principal Financial Group Inc. now owns 546,796 shares of the company’s stock valued at $49,179,000 after purchasing an additional 529,308 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec raised its stake in DocuSign by 42.4% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company’s stock worth $90,625,000 after buying an additional 434,312 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in DocuSign by 5,660.8% during the third quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after buying an additional 431,295 shares during the period. 77.64% of the stock is owned by hedge funds and other institutional investors.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- Insider Buying Explained: What Investors Need to Know
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- High-Yield Dividend King PepsiCo Offers Value Too Good to Ignore
- 3 Fintech Stocks With Good 2021 Prospects
- Palantir Stock Surges After Blockbuster Earnings: What’s Next?
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.